Rational Pharmacotherapy in Cardiology

Advanced search

Actual Issues of the Cardiac Complications Risk Assessment and Correction in Non-Cardiac Surgery

Full Text:


Worldwide, more than 200 million non-cardiac surgeries are performed annually, and this number is constantly increasing; cardiac complications are the leading cause of death in such surgeries. So, in a multicenter study conducted in 27 countries, cardiovascular complications were present in 68% of cases of death in the postoperative period. Registers of recent years have shown that the number of such complications remains high, for example, with a dynamic assessment of troponins, perioperative myocardial damage was detected in 13-18% of cases. This review provides a critical analysis of the step-by-step algorithm for assessing cardiac risk of non-cardiac operations considering the emergence of new publications on this topic. The review discusses new data on risk assessment scales, functional state assessment, the use of non-invasive tests, biomarkers, the role of preventive myocardial revascularization in the preoperative period, and drug therapy. The issues of non-cardiac operations after percutaneous coronary intervention, perioperative myocardial damage are considered separately. The review emphasizes the difficulties in obtaining evidence, conducting randomized clinical trials in this section of medicine, which do not allow obtaining unambiguous conclusions in most cases and lead to inconsistencies and ambiguities in the recommendations of various expert groups. This review will help practitioners navigate this issue and help to use the optimal diagnostic and treatment strategy before performing non-cardiac surgery.

About the Author

A. N. Sumin
Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation

Alexei N. Sumin – MD, PhD, Chief of Department of Multifocal Atherosclerosis 

Sosnovy Bulvar 6, Kemerovo, 650002 


1. Devereaux P.J., Sessler D.I. Cardiac complications in patients undergoing major noncardiac surgery. N Engl J Med. 2015;373:2258-69. DOI:10.1056/NEJMra1502824.

2. The Vascular Events in Noncardiac Surgery Patients Cohort Evaluation (VISION) Study Investigators. Association between complications and death within 30 days after noncardiac surgery. CMAJ. 2019;191(30):E830-E837. DOI:10.1503/cmaj.190221.

3. International Surgical Outcomes Study group. Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries. Br J Anaesth. 2016;117(5):601-9. DOI:10.1093/bja/aew316.

4. Smilowitz N.R., Gupta N., Guo Y., et al. Perioperative acute myocardial infarction associated with noncardiac surgery. Eur Heart J. 2017;38(31):2409-17. DOI:10.1093/eurheartj/ehx313.

5. Smilowitz N.R., Gupta N., Guo Y., et al. Trends in cardiovascular risk factor and disease prevalence in patients undergoing non-cardiac surgery. Heart. 2018;104(14):1180-6. DOI:10.1136/heartjnl2017-312391.

6. Smilowitz N.R., Gupta N., Ramakrishna H., et al. Perioperative Major Adverse Cardiovascular and Cerebrovascular Events Associated With Noncardiac Surgery. JAMA Cardiol. 2017;2(2):181-7. DOI:10.1001/jamacardio.2016.4792.

7. Fleisher L.A., Fleischmann K.E., Auerbach A.D., et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:e278-333. DOI:10.1161/CIR.0000000000000106.

8. Kristensen S.D., Knuuti J., Saraste A., et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: the Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014;35:2383-431. DOI:10.1093/eurheartj/ehu282.

9. Sumin A.N., Sumin D.A. Assessment and reduction of cardiac complications risk in non-cardiac operations: whether there are differences between European and American guidelines in 2014? Kreativnaya Kardiologiya. 2015;1:5-18 (In Russ.) DOI:10.15275/kreatkard.2015.01.01.

10. Khanna S., Argalious M. CON: Revised Cardiac Risk Index Should Be Used in Preference to American College of Surgeons National Surgical Quality Improvement Program Surgical Risk Calculator for Estimating Cardiac Risk in Patients Undergoing Noncardiac Surgery. J Cardiothorac Vasc Anesth. 2018;32(5):2420-2. DOI:10.1053/j.jvca.2018.06.031.

11. Sankar A., Johnson S.R., Beattie W.S., et al. Reliability of the American Society of Anesthesiologists physical status scale in clinical practice. Br J Anaesth. 2014;113(3):424-32. DOI:10.1093/bja/aeu100.

12. De Cassai A., Boscolo A., Tonetti T., et al. Assignment of ASA-physical status relates to anesthesiologists' experience: a survey-based national-study. Korean J Anesthesiol. 2019;72(1):53-9. DOI:10.4097/kja.d.18.00224.

13. Yap M.K.C., Ang K.F., Gonzales-Porciuncula L.A., Esposo E. Validation of the American College of Surgeons Risk Calculator for preoperative risk stratification. Heart Asia. 2018;10(2):e010993. DOI:10.1136/heartasia-2017-010993.

14. Wijeysundera D.N., Pearse R.M., Shulman M.A., et al.; METS study investigators. Assessment of functional capacity before major non-cardiac surgery: an international, prospective cohort study. Lancet. 2018;391(10140):2631-40. DOI:10.1016/S0140-6736(18)31131-0.

15. Duceppe E, Parlow J., MacDonald P., et al. Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery. Can J Cardiol. 2017;33(1):17-32. DOI:10.1016/j.cjca.2016.09.008.

16. Gualandro D.M., Yu P.C., Caramelli B., et al. 3rdGuideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology. Arq Bras Cardiol. 2017;109(3Suppl.1):1-104.

17. Reeves T., Bates S., Sharp T., et al; Perioperative Exercise Testing and Training Society (POETTS). Cardiopulmonary exercise testing (CPET) in the United Kingdom-a national survey of the structure, conduct, interpretation and funding. Perioper Med (Lond). 2018;7:2. DOI:10.1186/s13741-017-0082-3.

18. Shulman M.A., Cuthbertson B.H., Wijeysundera D.N., et al; Measurement of Exercise Tolerance for Surgery Study Investigators. Using the 6-minute walk test to predict disability-free survival after major surgery. Br J Anaesth. 2019;122(1):111-9. DOI:10.1016/j.bja.2018.08.016.

19. Kalesan B., Nicewarner H., Intwala S., et al. Pre-operative stress testing in the evaluation of patients undergoing non-cardiac surgery: A systematic review and meta-analysis. PLoS ONE. 2019;14(7):e0219145. DOI:10.1371/journal.pone.0219145.

20. Poldermans D., Bax J.J., Schouten O., et al. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control? Journal of the American College of Cardiology. 2006;48(5):964-9. DOI:10.1016/j.jacc.2006.03.059.

21. Sumin A.N. The assessment and reduction of cardiac events risk in noncardiac operations: is there a need for review of recommendations? Rational Pharmacotherapy in Cardiology. 2013;9(5):570-6 (In Russ.) DOI: 10.20996/1819-6446-2013-9-5-570-576.

22. Bouri S., Shun-Shin M.J., Cole G.D., et al. Meta-analysis of secure randomised controlled trials of beta-blockade to prevent perioperative death in non-cardiac surgery. Heart. 2014;100:456-64. DOI:10.1136/heartjnl-2013-304262.

23. Kaw R., Nagarajan V., Jaikumar L., et al. Predictive Value of Stress Testing, Revised Cardiac Risk Index, and Functional Status in Patients Undergoing Noncardiac Surgery. J Cardiothorac Vasc Anesth. 2019;33(4):927-32. DOI:10.1053/j.jvca.2018.07.020.

24. Valle J.A., Graham L., Thiruvoipati T., et al. Facility-level association of preoperative stress testing and postoperative adverse cardiac events. Heart. 2018;104(24):2018-25. DOI:10.1136/heartjnl2018-313047.

25. Wijeysundera D.N., Beattie W.S., Austin P.C., et al. Non-invasive cardiac stress testing before elective major non-cardiac surgery: population based cohort study. BMJ. 2010;340:b5526. DOI:10.1136/bmj.b5526.

26. Levett D.Z.H., Jack S., Swart M., et al; Perioperative Exercise Testing and Training Society (POETTS). Perioperative cardiopulmonary exercise testing (CPET): consensus clinical guidelines on indications, organization, conduct, and physiological interpretation. Br J Anaesth. 2018;120(3):484-500. DOI:10.1016/j.bja.2017.10.020.

27. Koshy A.N., Ha F.J., Gow P.J., et al. Computed tomographic coronary angiography in risk stratification prior to non-cardiac surgery: a systematic review and meta-analysis. Heart. 2019;105(17):1335- 42. DOI:10.1136/heartjnl-2018-314649.

28. Sheth T., Chan M., Butler C., et al.; Coronary Computed Tomographic Angiography and Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study Investigators. Prognostic capabilities of coronary computed tomographic angiography before non-cardiac surgery: prospective cohort study. BMJ. 2015;350:h1907. DOI:10.1136/bmj.h1907.

29. Dowsley T.F., Sheth T., Chow B.J.W. Complementary pre-operative risk assessment using coronary computed tomography angiography and nuclear myocardial perfusion imaging in non-cardiac surgery: A VISION-CTA sub-study. J Nucl Cardiol. 2020;27(4):1331-7. DOI:10.1007/s12350-019-01779-9.

30. Sumin A.N., Korok E.V., Panfilov S.D., et al. Comparison of two strategies to minimize the risk of cardiac complications following vascular surgeries: long-term results. Kompleksnye Problemy SerdechnoSosudistykh Zabolevaniy. 2013;3:18-25 (In Russ.)

31. Alekyan B.G., Pokrovsky A.V., Karapetyan N.G., Revishvili A.Sh. A multidisciplinary approach in determining of prevalence of coronary artery disease and treatment strategies in patients with pathology of the aorta and peripheral arteries. Russian Journal of Cardiology. 2019;24(8):8-16 (In Russ.) DOI:10.15829/1560-4071-2019-8-8-16.

32. Devereaux P.J., Duceppe E., Guyatt G., et al. Dabigatran in patients with myocardial injury after noncardiac surgery (MANAGE ): an international, randomised, placebocontrolled trial. Lancet. 2018;391:2325-34. DOI:10.1016/S0140-6736(18)30832-8.

33. Newby D.E., Adamson P.D., Berry C., et al; SCOT-HEART Investigators. Coronary CT Angiography and 5-Year Risk of Myocardial Infarction. N Engl J Med. 2018;379:924-33. DOI:10.1056/NEJMoa1805971.

34. Rodseth R.N., Biccard B.M., Le Manach Y., et al. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis. J Am Coll Cardiol. 2014;63:170-80. DOI:10.1016/j.jacc.2013.08.1630.

35. Zhang L.J., Li N., Li Y., et al. Cardiac Biomarkers Predicting MACE in Patients Undergoing Noncardiac Surgery: A Meta-Analysis. Front Physiol. 2019;9:19-23. DOI:10.3389/fphys.2018.01923

36. Devereaux P.J., Biccard B.M., Sigamani A., et al. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2017;317:1642-51. DOI:10.1001/jama.2017.4360.

37. Devereaux P.J., Szczeklik W. Myocardial injury after non-cardiac surgery: diagnosis and management. Eur Heart J. 2020;41(32):3083-91. DOI:10.1093/eurheartj/ehz301.

38. McFalls E.O., Ward H.B., Moritz T.E., et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351:2795-804. DOI:10.1056/NEJMoa041905.

39. Illuminati G., Schneider F., Greco C., et al. Long-term results of a randomized controlled trial analyzing the role of systematic pre-operative coronary angiography before elective carotid endarterectomy in patients with asymptomatic coronary artery disease. Eur J VascEndovasc Surg. 2015;49(4):366-74. DOI:10.1016/j.ejvs.2014.12.030.

40. Xia J., Qu Y., Yin C., Xu D. Preoperative rosuvastatin protects patients with coronary artery disease undergoing noncardiac surgery. Cardiology. 2015;131(1):30-7. DOI:10.1159/000371872.

41. Berwanger O., de Barros E., Silva P.G., et al; LOAD Investigators. Atorvastatin for high-risk statinnaïve patients undergoing noncardiac surgery: The Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose (LOAD) randomized trial. Am Heart J. 2017;184:88-96. DOI:10.1016/j.ahj.2016.11.001.

42. Putzu A., de Carvalho E., Silva C.M.P.D., et al. Perioperative statintherapy in cardiac and non-cardiacsurgery: a systematic review and meta-analysis of randomized controlled trials. AnnIntensive Care. 2018;8(1):95. DOI:10.1186/s13613-018-0441-3.

43. Yu W., Wang B., Zhan B., et al. Statintherapyimprovedlong-termprognosis in patients with major non-cardiac vascular surgeries: a systematic review and meta-analysis. Vascul Pharmacol. 2018;109:1-16. DOI:10.1016/j.vph.2018.06.015.

44. Berwanger O., Le Manach Y., Suzumura E.A., et al. Association between preoperative statin use and major cardiovascular complications among patients undergoing non-cardiac surgery: the VISION study. Eur Heart J. 2016;37(2):177-85. DOI:10.1093/eurheartj/ehv456.

45. Mohebi R., Rosenson R. Statins in the perioperative period [version 1; peer review: 3 approved]. F1000Research. 2019;8(F1000 Faculty Rev):688. DOI:10.12688/f1000research.17572.1.

46. Jørgensen M.E., Andersson C., Venkatesan S., Sanders R.D. Beta-blockers in noncardiac surgery: Did observational studies put us back on safe ground? Br J Anaesth. 2018;121(1):16-25. DOI:10.1016/j.bja.2018.02.004.

47. Blessberger H., Lewis S.R., Pritchard M.W., et al. Perioperative beta-blockers for preventing surgeryrelated mortality and morbidity in adults undergoing non-cardiac surgery. Cochrane Database Syst Rev. 2019;9:CD013438. DOI:10.1002/14651858.CD013438.

48. Devereaux P.J. POISE-2 Investigators. Rationale and design of the Peri-Operative ISchemic Evaluation-2 (POISE-2) trial: an international 2 x 2factorial randomized controlled trial of acetyl-salicylic acid vs. placebo and clonidine vs. placebo in patients undergoing noncardiac surgery. Am Heart J. 2014;167:804-809.e4. DOI:10.1016/j.ahj.2014.01.007.

49. Valgimigli M., Bueno H., Byrne R.A., et al; ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39(3):213-60. DOI:10.1093/eurheartj/ehx419.

50. Smilowitz N.R., Lorin J., Berger J.S. Risks of noncardiac surgery early after percutaneous coronary intervention. Am Heart J. 2019;217:64-71. DOI:10.1016/j.ahj.2019.07.010.

51. Smith B.B., Warner M.A., Warner N.S., et al. Cardiac Risk of Noncardiac Surgery After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents. Anesth Analg. 2019;128(4):621-8. DOI:10.1213/ANE.0000000000003408.

52. Dargham B.B., Baskar A., Tejani I., et al. Intravenous Antiplatelet Therapy Bridging in Patients Undergoing Cardiac or Non-Cardiac Surgery Following Percutaneous Coronary Intervention. Cardiovasc Revasc Med. 2019;20(9):805-11. DOI:10.1016/j.carrev.2018.11.018.

53. Childers C.P., Maggard-Gibbons M., Ulloa J.G., et al. Perioperative management of antiplatelet therapy in patients undergoing non-cardiac surgery following coronary stent placement: a systematic review. Syst Rev. 2018;7(1):4. DOI:10.1186/s13643-017-0635-z.

54. Armstrong E.J., Graham L.A., Waldo S.W., et al. Incomplete Revascularization Is Associated With an Increased Risk for Major Adverse Cardiovascular Events Among Patients Undergoing Noncardiac Surgery. JACC Cardiovasc Interv. 2017;10(4):329-38. DOI:10.1016/j.jcin.2016.11.001.

55. Thygesen K., Alpert J.S., Jaffe A.S., et al.; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018;72(18):2231-64. DOI:10.1016/j.jacc.2018.08.1038.

56. Puelacher C., LuratiBuse G., Seeberger D., et al. Perioperative myocardial injury after noncardiac surgery: incidence, mortality, and characterization. Circulation. 2018;137:1221-32. DOI:10.1161/CIRCULATIONAHA.117.030114.

57. Devereaux P.J., Xavier D., Pogue J., et al; POISE (PeriOperativeISchemic Evaluation) Investigators. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery. A cohort study. Ann Intern Med. 2011;154:523-8. DOI:10.7326/0003-4819-154-8-201104190-00003.

58. Parashar A., Agarwal S., Krishnaswamy A., et al. Percutaneous intervention for myocardial infarction after noncardiac surgery: patient characteristics and outcomes. J Am Coll Cardiol. 2016;68:329-38. DOI:10.1016/j.jacc.2016.03.602.

59. Sheth T., Natarajan M.K., Hsieh V., et al. Incidence of thrombosis in perioperative and nonoperative myocardial infarction. Br J Anaesth. 2018;120:725-33. DOI:10.1016/j.bja.2017.11.063.

60. Buse G.L., Manns B., Lamy A., et al. Troponin T monitoring to detect myocardial injury after noncardiac surgery: a cost-consequence analysis. Can J Surg. 2018;61(3):185-94. DOI:10.1503/cjs.010217.

For citation:

Sumin A.N. Actual Issues of the Cardiac Complications Risk Assessment and Correction in Non-Cardiac Surgery. Rational Pharmacotherapy in Cardiology. 2020;16(5):749-758. (In Russ.)

Views: 147

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)